Search

Author/Creator van der Woude, C. Janneke

2. Fecal Matrix Metalloproteinase-9 Measurement for Optimizing Detection of Disease Activity in Inflammatory Bowel Disease. Issue 5 (May 2019)

Authors:
Kreijne, Joany E.; van der Giessen, Janine; Verhaar, Auke P.; Peppelenbosch, Maikel P.; de Vries, Annemarie C.; van der Woude, C. Janneke; Fuhler, Gwenny M.
Journal:
Journal of clinical gastroenterology
Issue:
Volume 53:Issue 5(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Limited added value of laboratory monitoring in thiopurine maintenance monotherapy in inflammatory bowel disease patients. Issue 12 (28th April 2020)

Authors:
Kreijne, Joany E.; de Vries, Annemarie C.; de Veer, Rozanne C.; Bouma, Gerd; Dijkstra, Gerard; Voskuil, Michiel D.; West, Rachel; van Moorsel, Sofia A. W.; de Jong, Dirk J.; de Boer, Nanne K.; van der Woude, C. Janneke
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 51:Issue 12(2020)
Page Start:
1353
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Off‐label prescriptions of drugs used for the treatment of Crohn's disease or ulcerative colitis. Issue 10 (25th March 2019)

Authors:
Simsek, Melek; Lissenberg‐Witte, Birgit I.; van Riswijk, Milou L. M.; Verschuren, Sander; Hoentjen, Frank; Oldenburg, Bas; Ponsioen, Cyriel Y.; van der Woude, C. Janneke; van der Meulen, Andrea E.; Pierik, Marieke; Dijkstra, Gerard; de Boer, Nanne K. H.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 49:Issue 10(2019)
Page Start:
1293
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Predicting Endoscopic Disease Activity in Crohn's Disease: A New and Validated Noninvasive Disease Activity Index (The Utrecht Activity Index). Issue 10 (October 2015)

Authors:
Minderhoud, Itta M.; Steyerberg, Ewout W.; van Bodegraven, Ad A.; van der Woude, C. Janneke; Hommes, Daniel W.; Dijkstra, Gerard; Fidder, Herma H.; Schwartz, Matthijs P.; Oldenburg, Bas
Journal:
Inflammatory bowel diseases
Issue:
Volume 21:Issue 10(2015:Oct.)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Pregnancy outcomes following periconceptional or gestational exposure to ustekinumab: Review of cases reported to the manufacturer's global safety database. Issue 3 (12th May 2022)

Authors:
Mahadevan, Uma; Naureckas, Saule; Tikhonov, Ilia; Wang, Yiting; Lin, Connie B.; Geldhof, Anja; van der Woude, C. Janneke
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 56:Issue 3(2022)
Page Start:
477
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti‐TNF or conventional therapy: results of the European CONCEIVE study. Issue 1 (6th November 2019)

Authors:
Moens, Annick; van der Woude, C. Janneke; Julsgaard, Mette; Humblet, Evelien; Sheridan, Juliette; Baumgart, Daniel C.; Gilletta De Saint‐Joseph, Cyrielle; Nancey, Stéphane; Rahier, Jean‐François; Bossuyt, Peter; Cremer, Anneline; Dewit, Sophie; Eriksson, Carl; Hoentjen, Frank; Krause, Thomas; Lou...
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 51:Issue 1(2020)
Page Start:
129
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Prevalence and Phenotype of Concurrent Psoriasis and Inflammatory Bowel Disease. Issue 10 (October 2017)

Authors:
Eppinga, Hester; Poortinga, Sietske; Thio, Hok Bing; Nijsten, Tamar E. C.; Nuij, Veerle J. A. A.; van der Woude, C. Janneke; Vodegel, Robert M.; Fuhler, Gwenny M.; Peppelenbosch, Maikel P.
Journal:
Inflammatory bowel diseases
Issue:
Volume 23:Issue 10(2017)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Real‐life study of safety of thiopurine‐allopurinol combination therapy in inflammatory bowel disease: myelotoxicity and hepatotoxicity rarely affect maintenance treatment. Issue 4 (30th July 2019)

Authors:
Kreijne, Joany E.; de Veer, Rozanne C.; de Boer, Nanne K.; Dijkstra, Gerard; West, Rachel; Moorsel, Sofia A. W.; de Jong, Dirk J.; van der Woude, C. Janneke; de Vries, Annemarie C.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 50:Issue 4(2019)
Page Start:
407
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗